MEDIKIT, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 3%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Mon Feb 10, 2025 4:00 pm JST Earnings

7749 MEDIKIT CO.,LTD 【J-GAAP】

Earnings Report

MEDIKIT CO.,LTD <7749> [TSE Std] announced its financial results after the market closed on February 10th (16:00). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) decreased 3.1% from the same period last year to 3.7 billion yen. However, the progress rate toward the full-year plan of 4.22 billion yen was 87.6%, also surpassing the five-year average of 80.9%.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to drop 45.5% from the same period last year to 0.52 billion yen.

In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit amounted to 1.42 billion yen, an increase of 0.4% compared to the same period last year. However, the operating profit margin decreased from 23.7% in the same period last year to 23.3%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Dec, 2022	16,448	3,319	3,393	2,128	126.8	81.2	Feb 10, 2023	J-GAAP
Apr - Dec, 2023	16,860	3,699	3,818	2,131	127.0	79.9	Feb 9, 2024	J-GAAP
Apr - Dec, 2024	17,342	3,629	3,701	2,155	146.0	87.6	Feb 10, 2025	J-GAAP
YoY	+2.9%	-1.9%	-3.1%	+1.1%	+15.0%

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	11,005	2,401	2,380	1,749	107.1	45	May 15, 2024	J-GAAP
Oct - Mar, 2024 Guidance	11,100	1,942	1,947	1,467	100.4	45	Nov 11, 2024	J-GAAP
YoY	+0.9%	-19.1%	-18.2%	-16.1%	-6.3%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	21,607	4,118	4,177	2,864	170.7	100	May 15, 2023	J-GAAP
Mar, 2024	21,850	4,677	4,781	3,069	188.0	80	May 15, 2024	J-GAAP
Mar, 2025 Guidance	22,385	4,162	4,226	2,745	187.8	90	May 15, 2024	J-GAAP
YoY	+2.4%	-11.0%	-11.6%	-10.6%	-0.1%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2023	6,015	1,423	1,417	811	48.3	23.7	Feb 9, 2024	J-GAAP
Jan - Mar, 2024	4,990	978	963	938	57.4	19.6	May 15, 2024	J-GAAP
Apr - Jun, 2024	5,628	1,078	1,107	405	27.4	19.2	Aug 9, 2024	J-GAAP
Jul - Sep, 2024	5,657	1,142	1,172	873	59.0	20.2	Nov 11, 2024	J-GAAP
Oct - Dec, 2024	6,057	1,409	1,422	877	59.4	23.3	Feb 10, 2025	J-GAAP
YoY	+0.7%	-1.0%	+0.4%	+8.1%	+23.0%